ArticleMedicine2026

Mechanism of afatinib resistance in non-small cell lung cancer patients with nonclassical EGFR mutations: A multicenter, retrospective study.

Ranpu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.